Characteristics of tumor infiltrating lymphocyte and circulating lymphocyte repertoires in pancreatic cancer by the sequencing of T cell receptors

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Bai, Xueli ^a   Zhang, Qi ^a   Wu, Song ^b,c   Zhang, Xiaoyu ^a   Wang, Mingbang ^d   He, Fusheng ^d   Wei, Tao ^a   Yang, Jiaqi ^a   Lou, Yu ^a   Cai, Zhiming ^b   Liang, Tingbo ^a,e  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY   (United States)

^d Siteman Cancer Center Washington University in St Louis ^*  (China)

^e ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARITY DETERMINING REGION; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA;

ADULT; AGED; BLOOD; CELL CLONE; COMPLEMENTARITY DETERMINING REGION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; SEQUENCE ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER; SEQUENCE ANALYSIS, PROTEIN;

EID: 84940865012     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13664     Document Type: Article

References (29)

1. Siegel, R. et al. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29, doi: 10.3322/caac.21208 (2014).
2. Dodson, L. F., Hawkins, W. G. & Goedegebuure, P. Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy 3, 517-537, doi: 10.2217/imt.11.10 (2011).
3. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577-581, doi: 10.1038/nature13988 (2014).
4. Restifo, N. P., Dudley, M. E. & Rosenberg, S. A. Adoptive immunotherapy for cancer: harnessing the T cell response. Nature Rev Immunol 12, 269-281, doi: 10.1038/nri3191 (2012).
5. Haanen, J. B. et al. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. Cancer Immunol Immunother 55, 451-458, doi: 10.1007/s00262-005-0018-5 (2006).
6. Gooden, M. J. et al. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with metaanalysis. Brit J Cancer 105, 93-103, doi: 10.1038/bjc.2011.189 (2011).
7. Akbay, E. A. et al. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors. Cancer Dis 3, 1355-1363, doi: 10.1158/2159-8290.CD-13-0310 (2013).
8. Swartz, M. A. et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 72, 2473-2480 doi: 10.1158/0008-5472.CAN-12-0122 (2012).
9. Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90-94, doi: 10.1038/nature09807 (2011).
10. Nikolich-Zugich, J., Slifka, M. K. & Messaoudi, I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol 4, 123-132, doi: 10.1038/nri1292 (2004).
11. Robins, H. S. et al. Digital genomic quantification of tumor-infiltrating lymphocytes. Sci Transl Med 5, 214ra169, doi: 10.1126/scitranslmed.3007247 (2013).
12. Hodges, E. et al. Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 56, 1-11 (2003).
13. Freeman, J. D. et al. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 19, 1817-1824, doi: 10.1101/gr.092924.109 (2009).
14. Xu, J. L. & Davis, M. M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13, 37-45 (2000).
15. Linnemann, C., Mezzadra, R. & Schumacher, T. N. TCR repertoires of intratumoral T-cell subsets. Immunol Res 257, 72-82, doi: 10.1111/imr.12140 (2014).
16. Emerson, R. O. et al. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J Pathol 231, 433-440, doi: 10.1002/path.4260 (2013).
17. Gerlinger, M. et al. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. J Pathol 231, 424-432, doi: 10.1002/path.4284 (2013).
18. van Heijst, J. W. et al. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med 19, 372-377, doi: 10.1038/nm.3100 (2013).
19. Turner, N. C. & Reis-Filho, J. S. Genetic heterogeneity and cancer drug resistance. Lancet Oncol 13, e178-185, doi: 10.1016/S1470-2045(11)70335-7 (2012).
20. Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328-337, doi: 10.1038/nature12624 (2013).
21. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366, 883-892, doi: 10.1056/NEJMoa1113205 (2012).
22. Samuel, N. & Hudson, T. J. The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma. Nat Rev Gastroenterol Hepatol 9, 77-87, doi: 10.1038/nrgastro.2011.215 (2012).
23. Lotzova, E. Role of human circulating and tumor-infiltrating lymphocytes in cancer defense and treatment. Nat Immu Cell Growth Regul 9, 253-264, (1990).
24. Qi, Q. et al. Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci 111, 13139-13144, doi: 10.1073/pnas.1409155111 (2014).
25. Le, D. et al. Safety and survival with GVAX pancreas prime and listeria monocytogenes-expressing mesothelin (CRS-207) boost vaccine for metastatic pancreatic cancer. J Clin Oncol 33, 1325-1333, doi: 10.1200/JCO.2014.57.4244 (2015).
26. Chmielewski, M., Hombach, A. A. & Abken, H. Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells. Front Immunol 4, 37, doi: 10.3389/fimmu.2013.00371 (2013).
27. McGranahan, N. & Swanton, C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27, 15-26, doi: 10.1016/j.ccell.2014.12.001 (2015).
28. Yousfi Monod, M. et al. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 20 Suppl 1, i379-385, doi: 10.1093/bioinformatics/bth945 (2004).
29. Britanova, O. V. et al. Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J immunol 192, 2689-2698, doi: 10.4049/jimmunol.1302064 (2014).